124 results
DEFA14A
FRTX
Fresh Tracks Therapeutics, Inc.
13 Nov 23
Additional proxy soliciting materials
8:58am
of innovative and ground-breaking prescription therapeutics. Unfortunately, after conducting an extensive, months-long process to explore and evaluate potential
DEFA14A
x9u6o 33q0p1b1o7gb
13 Nov 23
Additional proxy soliciting materials
8:48am
8-K
EX-99.1
t06ix
13 Nov 23
Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
8:33am
8-K
EX-99.1
k0zi9u
11 Aug 23
Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-99.1
625bhh
21 Jul 23
Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix
8:02am
8-K
EX-99.1
5zfkx
10 May 23
Fresh Tracks Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:04pm
8-K
EX-99.1
8not7
30 Mar 23
Fresh Tracks Therapeutics Reports Fourth Quarter and Full Year 2022
4:03pm
8-K
EX-99.1
puns927 11
10 Nov 22
Fresh Tracks Therapeutics Reports Third Quarter 2022
4:10pm